BIA Events

The leadership development programme for leaders in the Life Sciences

The over-arching theme for this edition of the Congress is “Shaping tomorrow: Biotechnology for Health, Food, Energy, Environment” — issues of global importance that demand collaboration across Industry, Academia, Research Institutes, and national governments.

Stevenage Bioscience Catalyst invites colleagues, partners and members of the wider life sciences community to join us in honouring and celebrating the life of our late CEO, Dr Sally Ann Forsyth OBE DSc, at a memorial gathering taking place at 3pm on Wednesday 1 July in the SBC Atrium.

GDES2026 is the premier international virtual conference for leading endocrinologists, diabetologists, and metabolic researchers from around the globe. Taking place on July 02-03, 2026, this congress is a vital platform for the dissemination of cutting-edge endocrine research and diabetes treatment strategies.

What’s Next for Translational Research? Are you ready to challenge the status quo in drug development? Join industry pioneers at ARC Oxford on July 2 for the Creative Disruption Forum. Hosted by Prof Tony Sedgwick and Graham Combe, this high-energy event is designed to break down the traditional silos separating discovery from clinical execution. Through engaging keynote interviews and collaborative afternoon workshops, we will tackle the skyrocketing complexities of new modalities and modern therapeutics. If you are a biotech leader, investor, or R&D director eager to accelerate discoveries from the bench straight to the patient, this is your sandbox. Don't just follow the future—disrupt it.

The Milner Institute's annual showcase highlights promising Pre-Series A companies from our bio-incubator, local accelerators, as well as other selected national and international companies.

Bringing together 25+ speakers and 60+ senior attendees from AstraZeneca, Genmab, Immunocore, Merus, Sanofi, Roche, and more the inaugural World Bispecific Summit Europe it’s set to be a key meeting point for teams driving discovery, engineering, CMC, safety, and clinical development of bispecifics.

The Milner Therapeutics Symposium is an annual flagship event in Cambridge, bringing together 750 leading scientists, innovators and investors from academia and industry.

Transitioning from preclinical development into first-in-human studies is one of the most critical and complex stages in drug development. Early strategic decisions can significantly influence timelines, regulatory interactions, study success and overall programme progression. Join our live Q&A webinar to put your questions to experts who have seen and done it all, and gain practical insight into navigating the path from preclinical promise to clinical reality.

Bionow's Neuroscience Conference brings together academics, clinicians and industry leaders to explore breakthroughs in the discovery, development and delivery of treatments for neurological diseases.